Inomagen Therapeutics, Inc. — Form D
Inomagen Therapeutics, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-24. The offering totals $400K, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-11-24
- Form: D
- Accession: 0001626370-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $200K
- Remaining: $200K
- Minimum investment: $25K
- Investors: 8
- Date of first sale: 2014-11-12
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-228972
Issuer
- Name: Inomagen Therapeutics, Inc.
- CIK: 0001626370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1375 W Fulton Street, CHICAGO, IL, 60607
- Phone: 312 805 8701
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Rishi Arora | Director | Chicago, IL |
| Rishi Arora | Executive Officer | Chicago, IL |
| Marc R Penn | Director | Chicago, IL |
| James R Vogler | Director | Chicago, IL |
Other filings by this issuer (2)
More